Warburg Pincus-Led Investor Group Acquires Controlling Stake in PANTHERx Rare
July 13, 2026
Warburg Pincus announced that a Warburg Pincus-led investor group agreed to acquire a controlling interest in PANTHERx Rare, a leading independent rare pharmacy in the United States. The sellers include Nautic Partners, General Atlantic, and The Vistria Group, while Nautic Partners and PANTHERx management are expected to remain significant shareholders.
- Buyers
- Warburg Pincus
- Targets
- PANTHERx Rare
- Sellers
- Nautic Partners, General Atlantic, The Vistria Group
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.